Welcoming two new members to our Strategic Innovation Advisory Board
Graciela Mabel Woloj Rothstein and Mikkel Z. Oestergaard, PhD join the board this March
Join us at the American Society of Hematology (ASH)
Traveling to the American Society of Hematology’s (ASH) annual meeting on December 7–10? We hope to see you at one of our sessions! Save these events to your calendar:
The Max Foundation and iCMLf: Forum for Physicians from Emerging Economic Regions
When & Where:
Friday, December 6, from 12–2 p.m. at the Rosen Plaza Hotel in Orlando, Florida.
Each year, ASH joins thousands of leaders around the world who are working to conquer blood diseases. This is a special opportunity for ASH attendees to share insight and chat with physicians practicing in under-resourced countries.
Discussion topics:
- Perspectives on the future of CML
- Modeling responses when testing less frequently than monthly
- Re-evaluating TKI use in pregnancy in 2019
Get to know the speakers:
- Professor Jorge Cortes, USA | Professional Bio
- Associate Professor Susan Branford, Australia | Professional Bio
- Dr. Carla Boquimpani, Brazil |Professional Bio
Plan on joining?
To reserve your place, please email Arlene Harris-Buchan.
FYI: The Rosen Plaza Hotel is about a 10-minute walk from the Orange County Convention Center.
Patients, Borders, Money, and Mission: A Global Perspective of Chronic Myeloid Leukemia
When & Where:
Two sessions on Saturday, Dec. 7 | 7:30–9 a.m. & 2–3:30 p.m. |Orange County Convention Center, W315, Level 3
Physicians in lower-income countries are facing challenges related to disease diagnosis, optimal management and monitoring, and providing access to treatment for patients with rare blood diseases. As part of ASH Education program, this session will discuss the obstacles of providing services in low-income countries, and how international partnerships are tackling these barriers.
Peek inside the session:
Dr. Scott Ramsey, Director of Hutchinson Institute for Cancer Outcomes at Fred Hutch, will discuss issues related to introducing generic imatinib, costs, and outcomes for patients, and what the implications are for care as second-generation TKIs become available as generics.
Dr. Hemant Malhotra, Professor of Medicine & Head, Division of Medical Oncology at Birla Cancer Center, will focus on disease characteristics in resource-poor countries and the challenges with monitoring CML.
Dr. Jerald Radich, Faculty Member at Fred Hutch, will discuss the problem of BCR-ABL monitoring in areas where a large number of patients have minimal laboratory facilities for RT-PCR testing. He’ll highlight the innovative ways and means for testing and transporting blood samples.
Pat Garcia-Gonzalez, CEO, The Max Foundation, will highlight the challenges when TKIs and basic diagnostics are unavailable for CML patients living in low-income countries. She’ll also discuss the incredible efforts and partnerships The Max Foundation have made to address these issues.
Learn more about this session here.
The Max Foundation is a leading global health nonprofit organization dedicated to accelerating health equity. For 28 years, Max has pioneered practical, scalable, high-quality solutions to bring life-extending treatments and patient-centered health care to more than 100,000 people living with cancer and critical illness in low- and middle-income countries. Max believes in a world where all people can access high-impact medicines, where geography is not destiny, and where everyone can strive for health with dignity and with hope.
Related Articles
Welcoming Two New Board Members: Dr. Mika Matsuzaki and Dr. Susan M. Jerian
Please join us in welcoming Mika Matsuzaki, PhD, and Susan M. Jerian, MD to The Max Foundation Board of Directors.
First Doses of CLL treatment provided to Patients with Chronic Lymphocytic Leukemia in Low- and Middle-Income Countries Under Collaboration of The Max Foundation, BeiGene, and the BeiGene Foundation
Armenia and Nepal are the first of 29 countries to receive CLL treatment SEATTLE & BASEL & BEIJING & CAMBRIDGE, Mass. – March 13, 2024 — The Max Foundation (Max), a global nonprofit organization dedicated to accelerating health equity by delivering medication, technology, and supportive services to patients worldwide, BeiGene, a global oncology company, and….